Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 19/20 | 0.54 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30919237 | 0.95 | KISS1R (0.54) | KISS1R | |
| SCHEMBL29636525 | 0.94 | KISS1R (0.53) | KISS1R | |
| SCHEMBL34468395 | 0.94 | KISS1R (0.53) | KISS1R | |
| SCHEMBL29476642 | 0.93 | KISS1R (0.53) | KISS1R | |
| SCHEMBL31406265 | 0.93 | ERAP2 (0.54) | KISS1R | |
| SCHEMBL30903464 | 0.91 | KISS1R (0.56) | KISS1R | |
| SCHEMBL30529926 | 0.91 | KISS1R (0.58) | KISS1R | |
| SCHEMBL30529927 | 0.91 | KISS1R (0.58) | KISS1R | |
| SCHEMBL31607064 | 0.91 | ERAP2 (0.52) | KISS1R | |
| SCHEMBL29672123 | 0.91 | KISS1R (0.55) | KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12459894-B2 | Orally active melanocortin receptor-4 compounds | PALATIN TECHNOLOGIES, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| US-20220204450-A1 | Orally Active Melanocortin Receptor-4 Compounds | PALATIN TECHNOLOGIES, INC. (US) | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12459894-B2 | Orally active melanocortin receptor-4 compounds | MC4R, MC1R, MC3R | KISS1R 118/4885UTS2R 128/4885 |
| US-20220204450-A1 | Orally Active Melanocortin Receptor-4 Compounds | MC4R, MC1R, MC3R | KISS1R 118/4885UTS2R 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.